Investment bank, Piper Sandler, has announced the appointment of Patrick McCormick, MD, as a managing director in its healthcare investment banking group.
Dr. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions.
In a statement, Peter Day, global group head of healthcare investment banking at Piper Sandler, commented, “We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising biopharma companies across the full spectrum of equity and M&A transactions, combined with his rare scientific and clinical perspective, makes him an exceptional addition to our group. Patrick’s extensive relationships with management teams, boards of directors and investors across the sector will further strengthen our ability to deliver outstanding outcomes for our clients.”
Dr. McCormick remarked, “Piper Sandler has built one of the most respected healthcare investment banking franchises in the industry, and I am excited to join such a talented and driven team. I look forward to leveraging my experience advising biopharma companies to help clients navigate complex transactions and create long-term value.”
